Pathophysiology of itching in urticaria and atopic dermatitis
1992; Wiley; Volume: 47; Issue: 2PART1 Linguagem: Inglês
10.1111/j.1398-9995.1992.tb05091.x
ISSN1398-9995
Autores Tópico(s)Contact Dermatitis and Allergies
ResumoAllergyVolume 47, Issue 2PART1 p. 65-75 Free Access Pathophysiology of itching in urticaria and atopic dermatitis C.-F. Wahlgren M.D., Ph.D., Corresponding Author C.-F. Wahlgren M.D., Ph.D. Department of Dermatology, Karolinska Hospital, Stockholm, SwedenDepartment of Dermatology Karolinska Hospital S-104 01 Stockholm SwedenSearch for more papers by this author C.-F. Wahlgren M.D., Ph.D., Corresponding Author C.-F. Wahlgren M.D., Ph.D. Department of Dermatology, Karolinska Hospital, Stockholm, SwedenDepartment of Dermatology Karolinska Hospital S-104 01 Stockholm SwedenSearch for more papers by this author First published: April 1992 https://doi.org/10.1111/j.1398-9995.1992.tb05091.xCitations: 70AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Hafenreffer S. Nosodochium, in quo cutis, eique adhœrentium partium, affectus omnes, singulari methodo, et cognoscendi et curandi fidelissime traduntur. Ulm: Kühn, B, 1660: 98– 102. 2 Woodward DF, Conway JL, Wheeler LA. Cutaneous itching models. In: HI Maibach, NJ Lowe, eds. Models in dermatology, vol 1. Basel: Karger, 1985: 187– 95. 3 De Castro-Costa M. Gybels J. Kupers R., Van Hees J. Scratching behaviour in arthritic rats: a sign of chronic pain or itch Pain 1987: 29: 123– 31. 4 Savin JA, Paterson WD, Oswald I. Scratching during sleep. Lancet 1973: 2: 296– 7. 5 Savin JA, Paterson WD, Oswald I., Adam K. Further studies of scratching during sleep. Br J Dermatol 1975: 93: 297– 302. 6 Savin JA, Paterson WD, Adam K., Oswald I. Effects of trimeprazine and trimipramine on nocturnal scratching in patients with atopic eczema. Arch Dermatol 1979: 115: 313– 15. 7 Felix R., Shuster S. A new method for the measurement of itch and the response to treatment. Br J Dermatol 1975: 93: 303– 12. 8 Summerfield JA, Welch ME. The measurement of itch with sensitive limb movement meters. Br J Dermatol 1980: 102: 275– 81. 9 Aoki T., Kushimoto H., Kobayashi E., Ogushi Y. Computer analysis of nocturnal scratch in atopic dermatitis. Acta Derm Venereol (Stockh) 1980: Suppl 92: 33– 7. 10 Mustakallio KK, Räsänen T. Scratch radar [abstract]. Skin Pharmacol 1989: 2: 233. 11 Chapman CR, Casey KL, Dubner R., Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain 1985: 22: 1– 31. 12 Tuckett RP. Itch evoked by electrical stimulation of the skin. J Invest Dermatol 1982: 79: 368– 73. 13 Simone DA, Ngeow JYF, Whitehouse J., Becerra-Cabal L., Putterman GJ, LaMotte RH. The magnitude and duration of itch produced by intracutaneous injections of histamine. Somatosens Res 1987: 5: 81– 92. 14 Handwerker HO, Margerl W., Klemm F., Lang E., Westerman RA. Quantitative evaluation of itch sensation. In: RF Schmidt, HG Schaible, C. Vahle-Hinz, eds. Fine afferent nerve fibers and pain. Weinheim: VCH, 1987: 461– 73. 15 Wahlgren CF, Ekblom A., Hägermark Ö. Some aspects of the experimental induction and measurement of itch. Acta Derm Venereol (Stockh) 1989: 69: 185– 9. 16 Aitken RCB. Measurement of feelings using visual analogue scales. Proc R Soc Med 1969: 62: 989– 93. 17 Wahlgren CF, Hägermark Ö, Bergström R., Hedin B. Evaluation of a new method of assessing pruritus and antipruritic drugs. Skin Pharmacol 1988: 1: 3– 13. 18 Wahlgren CF, Hägermark Ö, Bergström R. The antipruritic effect of a sedative and an non-sedative antihistamine in atopic dermatitis. Br J Dermatol 1990: 122: 545– 51. 19 Wahlgren CF, Scheynius A., Hägermark Ö. Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol (Stockh) 1990: 70: 323– 29. 20 Wahlgren CF. Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol (Stockh) 1991: Suppl 165: 1– 53. 21 Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975: 1: 277– 99. 22 Shelley WB, Arthur RP. The neurohistology and neurophysiology of the itch sensation in man. Arch Dermatol 1957: 76: 296– 323. 23 Keele CA, Armstrong D. Substances producing pain and itch. London: E Arnold, 1964. 24 Shapiro PE. Braun CW. Unilateral pruritus after a stroke. Arch Dermatol 1987: 123: 1527– 30. 25 Torebjörk HE, Ochoa JL. Pain and itch from C fiber stimulation [abstract]. Soc Neurosci Abstr 1981: 7: 228. 26 Cormia FE. Experimental histamine pruritus I. Influence of physical and psychological factors on threshold reactivity. J Invest Dermatol 1952: 19: 21– 34. 27 Melzack R., Wall PD. Pain mechanisms: a new theory. Science 1965: 150: 971– 9. 28 Bickford RG. Experiments relating to the itch sensation, its peripheral mechanism, and central pathways. Clin Sci 19371938: 3: 377– 86. 29 LaMotte RH. Simone DA, Baumann TK, Shain CN, Alreja M. Hypothesis for novel classes of chemoreceptors mediating chemogenic pain and itch. In: R. Dubner, GF Gebhart, MR Bond, eds. Proceedings of the Vth world congress on pain. Amsterdam: Elsevier Science Publishers BV, 1988: 529– 35. 30 Arthur RP, Shelley WB. The role of proteolytic enzymes in the production of pruritus in man. J Invest Dermatol 1955: 25: 341– 6. 31 Hägermark Ö. Recent advances in the pathophysiology of itch. Allergologie 1989: 12: S139– 42. 32 Hägermark O. Studies on experimental itch induced by kallikrein and bradykinin. Acta Derm Venereol (Stockh) 1974: 54: 397– 400. 33 Hägermark Ö. Influence of antihistamines, sedatives, and aspirin on experimental itch. Acta Derm Venereol (Stockh) 1973: 53: 363– 8. 34 Greaves MW, McDonald-Gibson W. Itch: role of prostaglandins. BMJ 1973: 3: 608– 9. 35 Lovell CR, Burton PA, Duncan EHL, Burton JL. Prostaglandins and pruritus. Br J Dermatol 1976: 94: 273– 5. 36 Hägermark Ö, Strandberg K., Hamberg M. Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog. J Invest Dermatol 1977: 69: 527– 30. 37 Hägermark Ö, Strandberg K. Pruritogenic activity of prostaglandin E2. Acta Derm Venereol (Stockh) 1977: 57: 37– 43. 38 Fjellner B., Hägermark Ö. Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33–824, β-endorphin and morphine. Arch Dermatol Res 1982: 274: 29– 37. 39 Hägermark Ö. Itch and endorphins. In: J. Ring, G. Burg, eds. New trends in allergy II. Berlin-Heidelberg: Springer-Verlag, 1986: 128– 34. 40 Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978: 4: 451– 62. 41 Koenigstein H. Experimental study of itch stimuli in animals. Arch Dermatol Syphilol 1948: 57: 828– 49. 42 Ballantyne JC, Loach AB, Carr DB. Itching after epidural and spinal opiates. Pain 1988: 33: 149– 60. 43 Monroe EW. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. J Am Acad Dermatol 1989: 21: 135– 6. 44 Lewis T. The blood vessels of the human skin and their responses. London: Shaw & Sons, 1927. 45 Lewis T., Grant RT, Marvin HM. Vascular reactions of the skin to injury. Heart 19271929: 14: 139– 60. 46 Czarnetzki BM. Urticaria. Berlin-Heidelberg: Springer-Verlag, 1986. 47 Black Kobza A., Greaves MW, Champion RH, Pye RJ. The urticarias 1990. Br J Dermatol 1991: 124: 100– 8. 48 Soter NA. Acute and chronic urticaria and angioedema. J Am Acad Dermatol 1991: 25: 146– 54. 49 Hägermark Ö. Strandberg K. Grönneberg R. Effects of histamine receptor antagonist on histamine-induced responses in human skin. Acta Derm Venereol (Stockh) 1979: 59: 297– 300. 50 Owen DAA. H1- and H2-receptor antagonists. In: MW. Greaves S. Shuster eds. Pharmacology of the skin II. Berlin-Heidelberg: Springer-Verlag, 1989: 227– 37. 51 Cormia FE, Kuykendall V. Experimental histamine pruritus II. Nature: physical and environmental factors influencing development and severity. J Invest Dermatol 1953: 20: 429– 46. 52 Stahle-Bäckdahl M. Hägermark Ö Lins LE. The sensitivity of uremic and normal human skin to histamine. Acta Derm Venereol (Stockh) 1988: 68: 230– 5. 53 Larsen Schultz F. Genetic aspects of atopic eczema. In: T. Ruzicka J. Ring B. Przybilla, eds. Handbook of atopic eczema. Berlin-Heidelberg: Springer-Verlag, 1991: 15– 26. 54 Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980: Suppl 92: 44– 7. 55 Rajka G. Essential aspects of atopic dermatitis. Berlin-Heidelberg: Springer-Verlag, 1989. 56 Ring J. Ruzicka T., Przybilla B. The pathophysiology of atopic eczema: synopsis. In: T. Ruzicka, J. Ring, B. Przybilla, eds. Handbook of atopic eczema. Berlin-Heidelberg: Springer-Verlag, 1991: 330– 5. 57 Hanifin JM. Pharmacophysiology of atopic dermatitis. Clin Rev Allergy 1986: 4: 43– 65. 58 Leung DYM, Geha RS. Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy 1986: 4: 67– 86. 59 Hanifin JM. Immunologic aspects of atopic dermatitis. Dermatol Clin 1990: 8: 747– 50. 60 Wright S. Essential fatty acids and atopic dermatitis. Pediatr Allergy Immunol 1991: 2 Suppl 1: 23– 30. 61 Cooper KD. Pathogenesis and pharmacology of atopic dermatitis. In: JM Czernielewski, ed. Immunological and pharmacological aspects of atopic and contact eczema. Pharmacology and the skin, Vol 4. Basel: Karger, 1991: 119– 27. 62 Clark RAF. Cell-mediated and IgE-mediated immune responses in atopic dermatitis [editorial]. Arch Dermatol 1989: 125: 413– 16. 63 Bruynzeel-Koomen C. van Wichen DF, Toonstra J. Berrens L. Bruynzeel PLB. The presence of IgE-molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 1986: 278: 199– 205. 64 Barker JNWN, Alegre VA, MacDonald DM. Surface-bound immunoglobulin E on antigen-presenting cells in cutaneous tissue of atopic dermatitis. J Invest Dermatol 1988: 90: 117– 21. 65 Bieber T., Dannenberg B., Prinz JC, et al. Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J. Invest Dermatol 1989: 92: 215– 19. 66 Bieber T., Rieger A., Neuchrist C., et al. Induction of FcεR2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and γ interferon. J Exp Med 1989: 170: 309– 14. 67 Fokkens WJ, Bruijnzeel-Koomen CAFM, Vroom TM, et al. The Langerhans cell: an underestimated cell in atopic disease. Clin Exp Allergy 1990: 20: 627– 38. 68 Saarinen UM. Transfer of latent atopy by bone marrow transplantation? A case report. J Allergy Clin Immunol 1984: 74: 196– 200. 69 Parkman R. Rappeport J. Geha R. et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med 1978: 298: 921– 7. 70 Saurat JH. Eczema in primary immune-deficiencies. Acta Derma Venereol (Stockh) 1985: 114: 125– 8. 71 Lever R. Turbitt M. Sanderson A. MacKie R. Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 1987: 89: 4– 7. 72 Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976: 67: 305– 12. 73 Irani AMA, Sampson HA, Schwartz LB. Mast cells in atopic dermatitis. Allergy 1989: 44 Suppl 9: 31– 4. 74 Leiferman KM. Eosinophils in atopic dermatitis. Allergy 1989: 44 Suppl 9: 20– 6. 75 Jordan JM. Whitlock FA. Emotions and the skin: the conditioning of scratch responses in cases of atopic dermatitis. Br J Dermatol 1972: 86: 574– 85. 76 Wahlgren CF. Hägermark Ö. Bergström R. Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis. Acta Derm Venereol (Stockh) 1991: 71: 488– 94. 77 Lebel B., Venencie PY, Saurat JH, Soubrane C., Paupe J. Anti-IgE induced histamine release from basophils in children with atopic dermatitis. Acta Derm Venereol (Stockh) 1980: Suppl 92: 57– 9. 78 von der Helm D., Ring J., Dorsch W. Comparison of histamine release and prostaglandin E2 production of human basophils in atopic and normal individuals. Arch Dermatol Res 1987: 279: 536– 42. 79 Williams DH. Skin temperature reaction to histamine in atopic dermatitis (disseminated neurodermatitis). J Invest Dermatol 1938: 1: 119– 29. 80 Johnson HH, De Oreo GA, Lascheid WP, Mitchell F. Skin histamine levels in chronic atopic dermatitis. J Invest Dermatol 1960: 34: 237– 8. 81 Juhlin L. Localization and content of histamine in normal and diseased skin. Acta Derm Venereol (Stockh) 1967: 47: 383– 91. 82 Ruzicka T., Glück S. Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome. Arch Dermatol Res 1983: 275: 41– 4. 83 Ring J. Plasma histamine concentrations in atopic eczema. Clin Allergy 1983: 13: 545– 52. 84 Cormia FE, Dougherty JW. Clinical evaluation of antipruritic drugs. Arch Dermatol 1959: 79: 172– 8. 85 Hurley HJ. Clinical techniques for evaluating antipruritics and topical dermatologic preparations. In: JH Nodine, PE Siegler, eds. Animal and clinical pharmacologic techniques in drug evaluation. Chicago: Year Book Medical Publ., 1964: 262– 5. 86 Epstein, E., Pinski JB. A blind study, Arch Dermatol 1964: 89: 548– 9. 87 Fischer RW. Comparison of antipruritic agents administered orally. JAMA 1968: 203: 418– 19. 88 Frosch PJ, Schwanitz HJ, Macher E. A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res 1984: 276: 36– 40. 89 Savin JA. Dow R., Harlow BJ, Massey H., Yee KF. The effect of a new non-sedative H1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema. Clin Exp Dermatol 1986: 11: 600– 2. 90 Doherty V., Sylvester DGH, Kennedy CTC, Harvey SG, Calthrop JG. Gibson JR. Treatment of itching in atopic eczema with antihistamines with a low sedative profile. BMJ 1989: 298: 96. 91 Berth-Jones J., Graham-Brown RAC. Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989: 121: 635– 7. 92 Krause L., Shuster S. Mechanism of action of antipruritic drugs. BMJ 1983: 287: 1199– 200. 93 Tasaka K. Mio M., Okamoto M. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy 1986: 56: 464– 9. 94 Kreutner W., Chapman RW, Gulbenkian A. Siegel MI. Antiallergic activity of loratadine, a non-sedating antihistamine. Allergy 1987: 42: 57– 63. 95 Leprevost C. Capron M. De Vos C. Tomassini M., Capron A. Inhibition of eosinophil chemotaxis by a new anti-allergic compound (cetirizine). Int Arch Allergy Appl Immunol 1988: 87: 9– 13. 96 Uehara M., Izukura R., Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990: 15: 264– 66. 97 Wassom DL, Loegering DA, Solley GO, et al. Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest 1981: 67: 651– 61. 98 Jakob T., Hermann K., Ring J. Eosinophil cationic protein in atopic eczema. Arch Dermatol Res 1991: 283: 5– 6. 99 Bruynzeel-Koomen CAFM van Wichen DF, Spry CJF. Venge P. Bruynzeel PLB. Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol 1988: 118: 229– 38. 100 Zheutlin LM, Ackerman SJ, Gleich GJ, Thomas LL. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol 1984: 133: 2180– 5. 101 Leiferman KM, Loegering DA, Gleich GJ. Production of wheal-and-flare skin reactions by eosinophil granule proteins [abstract]. J Invest Dermatol 1984: 82: 414. 102 Reinhold U., Kukel S., Goeden B., Neumann U., Wehrmann W., Kreysel HW. Interleukin-4 promotes the expansion of skin-infiltrating lymphocytes from atopic dermatitis in vitro. J Invest Dermatol 1991: 96: 370– 5. 103 Reinhold U., Goeden B., Kukel S., Neumann U., Wehrmann W., Kreysel HW. In vitro expanded skin-infiltrating lymphocytes from atopic dermatitis lesions secrete high levels of interleukin-4 and low levels of interferon-gamma [abstract]. Skin Pharmacol 1991: 4: 38– 9. 104 van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing CD4 + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991: 97: 389– 94. 105 van der Heyden FL, Wierenga EA, Bos JD, Kapsenberg ML. Atopic eczema skin-derived T cell clones: allergen specificity and cytokine production [abstract]. Skin Pharmacol 1991: 4: 39– 40. 106 Lieschke GJ, Maher D., Cebon J., et al. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Ann Intern Med 1989: 110: 357– 64. 107 Kaplan G., Kiessling R., Teklemariam S., et al. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2. J Exp Med 1989: 169: 893– 907. 108 Gaspari AA, Lotze MT, Rosenberg SA, Stern JB, Katz SI. Dermatologic changes associated with interleukin 2 administration. JAMA 1987: 258: 1624– 9. 109 Wahlgren CF, Linder Tengvall M, Scheynius A. Effects of cyclosporin A in atopic dermatitis: expression in the skin of IgE, low-affinity Fc-IgE receptors, ICAM-1 and eosinophilic granulocytes. Eur J Dermatol 1992: 2: 112– 8. 110 Munro CS, Higgins EM, Marks JM, Daly BM. Friedmann PS, Shuster S. Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions. Br J Dermatol 1991: 124: 43– 8. 111 Higgins EM, Munro CM, Rees J., et al. Effects of cyclosporin on physiological and pharmacological reactions in skin [abstract]. J Invest Dermatol 1988: 91: 397. 112 Shaw LM. Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring. Clin Chem 1989: 35: 1299– 308. 113 Sharpe RJ, Arndt KA, Bauer SI, Maione TE. Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch Dermatol 1989: 125: 1359– 62. 114 Marone G., Triggiani M., Cirillo R., Giacummo A., Siri L., Condorelli M. Cyclosporin A inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells. Ricerc Clin Lab 1988: 18: 53– 9. 115 Cowan MA. Neurohistological changes in lichen simplex chronicus. Arch Dermatol 1964: 89: 562– 8. 116 Pincelli C., Fantini F., Massimi P., Girolomoni G., Seidenari S., Gianetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990: 122: 745– 50. 117 Giannetti A., Girolomoni G. Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 1989: 121: 681– 8. 118 Uehara M., Miyauchi H. The morphologic characteristics of dry skin in atopic dermatitis. Arch Dermatol 1984: 120: 1186– 90. 119 Melnik BC. Disturbances of epidermal lipid metabolism and barrier function in atopic eczema. In: T. Ruzicka, J. Ring, B. Przybilla, eds. Handbook of atopic eczema. Berlin-Heidelberg: Springer-Verlag, 1991: 296– 305. 120 Werner Y., Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol (Stockh) 1985: 65: 102– 5. 121 Fjellner B., Hägermark Ö. Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta Derm Venereol (Stockh) 1979: 59: 505– 12. 122 Hägermark Ö. Rajka G., Bergqvist U. Experimental itch in human skin elicited by rat mast cell chymase. Acta Derm Venereol (Stockh) 1972: 52: 125– 8. 123 Fjellner B., Hägermark Ö. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol (Stockh) 1981: 61: 245– 50. 124 Hägermark Ö, Hökfelt T., Pernow B. Flare and itch induced by substance P in human skin. J Invest Dermatol 1978: 71: 233– 5. 125 Camp RDR, Coutts AA, Greaves MW, Kay AB, Walport MJ. Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmacol 1983: 80: 497– 502. 126 Fjellner B., Hägermark Ö. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. Acta Derm Venereol (Stockh) 1985: 65: 409– 12. Citing Literature Volume47, Issue2PART1April 1992Pages 65-75 ReferencesRelatedInformation
Referência(s)